55285-43-3

Basic information

• Product Name: Benzenamine, 2,6-dichloro-3-methoxy-
• CAS NO: 55285-43-3
• Molecular Formula: C7H7Cl2NO
• Molecular Weight: 192.045
• Mol File: 55285-43-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzenamine, 2,6-dichloro-3-methoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenamine, 2,6-dichloro-3-methoxy-(55285-43-3)
• EPA Substance Registry System: Benzenamine, 2,6-dichloro-3-methoxy-(55285-43-3)

Safety Data

• Hazardous Substances Data: 55285-43-3(Hazardous Substances Data)

Upstream product

• 77-78-1 dimethyl sulfate 
• 1618-56-0 1,3-dichloro-4-methoxy-2-nitro-benzene 
• 7440-02-0 nickel 
• 38902-87-3 3-nitro-2,4-dichlorophenol 

Downstream Products

• 872509-55-2 2,6-dichloro-3-methoxyphenyl isocyanate 
• 1427407-33-7 2,6-dichloro-N-[[2-fluoro-5-(3-fluorophenyl)phenyl]methyl]-3-methoxyaniline 
• 1427407-34-8 2,4-dichloro-3-[[2-fluoro-5-(3-fluorophenyl)phenyl]methylamino]phenol 
• 1427407-35-9 ethyl 2-[2,4-dichloro-3-[[2-fluoro-5-(3-fluorophenyl)phenyl]methylamino]phenoxy]acetate 
• 1427406-18-5 2-[2,4-dichloro-3-[[2-fluoro-5-(3-fluorophenyl)phenyl]methylamino]phenoxy]acetic acid 
• 1427407-32-6 N-(2,6-dichloro-3-methoxy-phenyl)-2-fluoro-5-(3-fluorophenyl)benzamide 
• 1224639-54-6 N-(2,6-dichloro-3-methoxyphenyl)-2-(2,5-dichlorophenoxy)-5-fluoro-N-methylnicotinamide 
• 82401-41-0 2,6-dichloro-3-methoxyphenylisothiocyanate 
• 1618-62-8 2-(2,6-Dichloro-3-methoxy-phenylamino)-benzoic acid 
• 1431873-07-2 C₁₈H₁₄Cl₂N₆O 

Relevant articles and documents

ANILINE DERIVATIVES,THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

The present invention relates to aniline derivatives, to their preparation and to their therapeutic application.

PYRIMIDINE UREA DERIVATIVES AS KINASE INHIBITORS

The invention relates to compounds of formula (I) wherein the substituents X1, R1, R2, R3 and R4 have the meaning as set forth and explained in the description of the invention, to processes for the preparation of these compounds, pharmaceutical compositions containing same, the use thereof optionally in combination with one or more other pharmaceutically active compounds for the therapy of a disease which responds to an inhibition of protein kinase activity, and a method for the treatment of such a disease.